Selenium compounds, apoptosis and other types of cell death: An overview for cancer therapy

International Journal of Molecular Sciences

Volumn 13, Issue 8, 2012, Pages 9649-9672

  Sanmartín, Carmen ^a   Plano, Daniel ^a,b   Sharma, Arun K ^b   Palop, Juan Antonio ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b PENN STATE CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Autophagy; Cell death; Selenium

Indexed keywords

1,2 [BIS(1,2 BENZISOSELENAZOLONE 3 (2H) KETONE)]ETHANE; 1,3 SELENAZOLIN 4 ONE DERIVATIVE; 1,4 PHENYLENEBIS(METHYLENE)SELENOCYANATE; 2 BUTYLSELENAZOLIDINE 4 CARBOXYLIC ACID; 2 CYCLOHEXYLSELENAZOLIDINE 4 CARBOXYLIC ACID; 2,5 BIS(5 HYDROMETHYL 2 SELENIEYL) 3 HYDROXYMETHYL N METHYLPYRROLE; 5 PHENYLCARBAMOYLPENTYL SELENOCYANIDE; BIS(4 AMINOPHENYL)DISELENIDE; CASPASE 3; D 501036; DIPHENYLMETHYLSELENOCYANATE; DISELENIDE DERIVATIVE; DISELENODIPROPIONIC ACID; EBSELEN; GLUTATHIONE; ISATIN DERIVATIVE; ISOSELENOCYANATE DERIVATIVE; METHYLSELENINIC ACID; METHYLSELENOCYSTEINE; PHOSPHOTRANSFERASE; REACTIVE OXYGEN METABOLITE; SELENIDE DERIVATIVE; SELENIOUS ACID; SELENIUM DERIVATIVE; SELENIUM OXIDE; SELENOCYANATE DERIVATIVE; SELENOCYSTAMINE; SELENOCYSTEINE; SELENOMETHIONINE; SODIUM SELENITE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

APOPTOSIS; AUTOPHAGY; CANCER CHEMOTHERAPY; CELL DEATH; ENZYME ACTIVATION; ENZYME REGULATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MITOCHONDRION; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; NEOPLASMS; PATHOLOGY;

ANIMALS; CELL DEATH; HUMANS; NEOPLASMS; SELENIUM COMPOUNDS;

EID: 84865040299     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13089649     Document Type: Review

References (111)

1. Thomson, C.D. Assessment of requirements for selenium and adequacy of selenium status: A review. Eur. J. Clin. Nutr. 2004, 58, 391-402.
2. Goldhaber, S.B. Trace element risk assessment: Essentiality vs. toxicity. Regul. Toxicol. Pharmacol. 2003, 38, 232-242.
3. Navarro-Alarcon, M.; Cabrera-Vique, C. Selenium in food and the human body: A review. Sci. Total Environ. 2008, 400, 115-141.
4. Council, N.R. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids; The National Academies Press: Whasington, DC, USA, 2000.
5. Lu, J.; Holmgren, A. Selenoproteins. J. Biol. Chem. 2009, 284, 723-727.
6. Papp, L.V.; Lu, J.; Holmgren, A.; Khanna, K.K. From selenium to selenoproteins: Synthesis, identity, and their role in human health. Antioxid. Redox Signal. 2007, 9, 775-806.
7. Brozmanova, J.; Manikova, D.; Vlckova, V.; Chovanec, M. Selenium: A double-edged sword for defense and offence in cancer. Arch. Toxicol. 2010, 84, 919-938.
8. Zeng, H.; Combs, G.F., Jr. Selenium as an anticancer nutrient: Roles in cell proliferation and tumor cell invasion. J. Nutr. Biochem. 2008, 19, 1-7.
9. Cole-Ezea, P.; Swan, D.; Shanley, D.; Hesketh, J. Glutathione peroxidase 4 has a major role in protecting mitochondria from oxidative damage and maintaining oxidative phosphorylation complexes in gut epithelial cells. Free Radic. Biol. Med. 2012, 53, 488-497.
10. Sanmartin, C.; Plano, D.; Font, M.; Palop, J.A. Kinase regulation by sulfur and selenium containing compounds. Curr. Cancer Drug Targets 2011, 11, 496-523.
11. Wu, M.; Kang, M.M.; Schoene, N.W.; Cheng, W.H. Selenium compounds activate early barriers of tumorigenesis. J. Biol. Chem. 2010, 285, 12055-12062.
12. Zeng, H. Selenium as an essential micronutrient: Roles in cell cycle and apoptosis. Molecules 2009, 14, 1263-1278.
13. Valdiglesias, V.; Pasaro, E.; Mendez, J.; Laffon, B. In vitro evaluation of selenium genotoxic, cytotoxic, and protective effects: A review. Arch. Toxicol. 2010, 84, 337-351.
14. Rana, S.V. Metals and apoptosis: Recent developments. J. Trace Elem. Med. Biol. 2008, 22, 262-284.
15. Clark, L.C.; Combs, G.F., Jr.; Turnbull, B.W.; Slate, E.H.; Chalker, D.K.; Chow, J.; Davis, L.S.; Glover, R.A.; Graham, G.F.; Gross, E.G.; et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional prevention of cancer study group. JAMA 1996, 276, 1957-1963.
16. Duffield-Lillico, A.J.; Dalkin, B.L.; Reid, M.E.; Turnbull, B.W.; Slate, E.H.; Jacobs, E.T.; Marshall, J.R.; Clark, L.C. Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: An analysis of the complete treatment period of the nutritional prevention of cancer trial. BJU Int. 2003, 91, 608-612.
17. Lippman, S.M.; Klein, E.A.; Goodman, P.J.; Lucia, M.S.; Thompson, I.M.; Ford, L.G.; Parnes, H.L.; Minasian, L.M.; Gaziano, J.M.; Hartline, J.A.; et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: The selenium and vitamin E cancer prevention trial (select). JAMA 2009, 301, 39-51.
18. Weekley, C.M.; Aitken, J.B.; Musgrave, I.F.; Harris, H.H. Methylselenocysteine treatment leads to diselenide formation in human cancer cells: Evidence from X-ray absorption spectroscopy studies. Biochemistry 2012, 51, 736-738.
19. Tapiero, H.; Townsend, D.M.; Tew, K.D. The antioxidant role of selenium and seleno-ompounds. Biomed. Pharmacother. 2003, 57, 134-144.
20. Zeng, H.; Briske-Anderson, M.; Wu, M.; Moyer, M.P. Methylselenol, a selenium metabolite, plays common and different roles in cancerous colon HCT116 cell and noncancerous NCM460 colon cell proliferation. Nutr. Cancer 2012, 64, 128-135.
21. Singletary, K.; Milner, J. Diet, autophagy, and cancer: A review. Cancer Epidemiol. Biomark. Prev. 2008, 17, 1596-1610.
22. Ren, Y.; Huang, F.; Liu, Y.; Yang, Y.; Jiang, Q.; Xu, C. Autophagy inhibition through PI3K/Akt increases apoptosis by sodium selenite in NB4 cells. BMB Rep. 2009, 42, 599-604.
23. Suzuki, M.; Endo, M.; Shinohara, F.; Echigo, S.; Rikiishi, H. Rapamycin suppresses ros-dependent apoptosis caused by selenomethionine in A549 lung carcinoma cells. Cancer Chemother. Pharmacol. 2011, 67, 1129-1136.
24. Zeng, H.; Wu, M.; Botnen, J.H. Methylselenol, a selenium metabolite, induces cell cycle arrest in G1 phase and apoptosis via the extracellular-regulated kinase 1/2 pathway and other cancer signaling genes. J. Nutr. 2009, 139, 1613-1618.
25. Fang, W.; Han, A.; Bi, X.; Xiong, B.; Yang, W. Tumor inhibition by sodium selenite is associated with activation of c-jun NH2-terminal kinase 1 and suppression of beta-catenin signaling. Int. J. Cancer 2010, 127, 32-42.
26. Facompre, N.D.; El-Bayoumy, K.; Sun, Y.W.; Pinto, J.T.; Sinha, R. 1,4-phenylenebis (methylene)selenocyanate, but not selenomethionine, inhibits androgen receptor and Akt signaling in human prostate cancer cells. Cancer Prev. Res. 2010, 3, 975-984.
27. Nguyen, N.; Sharma, A.; Sharma, A.K.; Desai, D.; Huh, S.J.; Amin, S.; Meyers, C.; Robertson, G.P. Melanoma chemoprevention in skin reconstructs and mouse xenografts using isoselenocyanate-4. Cancer Prev. Res. 2011, 4, 248-258.
28. Sharma, A.K.; Kline, C.L.; Berg, A.; Amin, S.; Irby, R.B. The Akt inhibitor ISC-4 activates prostate apoptosis response protein-4 and reduces colon tumor growth in a nude mouse model. Clin. Cancer Res. 2011, 17, 4474-4483.
29. Krishnegowda, G.; Prakasha Gowda, A.S.; Tagaram, H.R.; Carroll, K.F.; Irby, R.B.; Sharma, A.K.; Amin, S. Synthesis and biological evaluation of a novel class of isatin analogs as dual inhibitors of tubulin polymerization and Akt pathway. Bioorg. Med. Chem. 2011, 19, 6006-6014.
30. Luo, H.; Yang, Y.; Huang, F.; Li, F.; Jiang, Q.; Shi, K.; Xu, C. Selenite induces apoptosis in colorectal cancer cells via Akt-mediated inhibition of beta-catenin survival axis. Cancer Lett. 2012, 315, 78-85.
31. Plano, D.; Ibáñez, E.; Calvo, A.; Palop, J.A.; Sanmartín, C. Novel library of selenocompounds as kinase modulators. Molecules 2011, 16, 6349-6364.
32. Ibanez, E.; Agliano, A.; Prior, C.; Nguewa, P.; Redrado, M.; Gonzalez-Zubeldia, I.; Plano, D.; Palop, J.A.; Sanmartin, C.; Calvo, A. The quinoline imidoselenocarbamate EI201 blocks the akt/mtor pathway and targets cancer stem cells leading to a strong antitumor activity. Curr. Med. Chem. 2012, 19, 3031-3043.
33. Kong, L.; Yuan, Q.; Zhu, H.; Li, Y.; Guo, Q.; Wang, Q.; Bi, X.; Gao, X. The suppression of prostate LNCaP cancer cells growth by selenium nanoparticles through Akt/MDM2/AR controlled apoptosis. Biomaterials 2011, 32, 6515-6522.
34. Nishina, A.; Kimura, H.; Kozawa, K.; Sommen, G.; Nakamura, T.; Heimgartner, H.; Koketsu, M.; Furukawa, S. A superoxide anion-scavenger, 1,3-selenazolidin-4-one suppresses serum deprivation-induced apoptosis in PC12 cells by activating MAP kinase. Toxicol. Appl. Pharmacol. 2011, 257, 388-395.
35. Ranawat, P.; Bansal, M.P. Decreased glutathione levels potentiate the apoptotic efficacy of selenium: Possible involvement of p38 and JNK MAPKs-In vitro studies. Mol. Cell Biochem. 2008, 309, 21-32.
36. Ranawat, P.; Bansal, M.P. Apoptosis induced by modulation in selenium status involves p38 MAPK and ROS: Implications in spermatogenesis. Mol. Cell Biochem. 2009, 330, 83-95.
37. Chung, C.Y.; Madhunapantula, S.V.; Desai, D.; Amin, S.; Robertson, G.P. Melanoma prevention using topical PBISe. Cancer Prev. Res. 2011, 4, 935-948.
38. Wang, Z.; Lee, H.J.; Chai, Y.; Hu, H.; Wang, L.; Zhang, Y.; Jiang, C.; Lu, J. Persistent p21Cip1 induction mediates G1 cell cycle arrest by methylseleninic acid in DU145 prostate cancer cells. Curr. Cancer Drug Targets 2010, 10, 307-318.
39. Li, Z.S.; Shi, K.J.; Guan, L.Y.; Jiang, Q.; Yang, Y.; Xu, C.M. Downregulation of protein kinase Calpha was involved in selenite-induced apoptosis of NB4 cells. Oncol. Res. 2010, 19, 77-83.
40. MacKenzie, S.H.; Schipper, J.L.; Clark, A.C. The potential for caspases in drug discovery. Curr. Opin. Drug Discov. Dev. 2010, 13, 568-576.
41. Wlodkowic, D.; Telford, W.; Skommer, J.; Darzynkiewicz, Z. Apoptosis and beyond: Cytometry in studies of programmed cell death. Methods Cell Biol. 2011, 103, 55-98.
42. Park, H.H. Structural features of caspase-activating complexes. Int. J. Mol. Sci. 2012, 13, 4807-4818.
43. Xing, F.; Li, S.; Ge, X.; Wang, C.; Zeng, H.; Li, D.; Dong, L. The inhibitory effect of a novel organoselenium compound BBSKE on the tongue cancer Tca8113 in vitro and in vivo. Oral Oncol. 2008, 44, 963-969.
44. Shiah, H.S.; Lee, W.S.; Juang, S.H.; Hong, P.C.; Lung, C.C.; Chang, C.J.; Chou, K.M.; Chang, J.Y. Mitochondria-mediated and p53-associated apoptosis induced in human cancer cells by a novel selenophene derivative, D-501036. Biochem. Pharmacol. 2007, 73, 610-619.
45. Li, Z.; Carrier, L.; Rowan, B.G. Methylseleninic acid synergizes with tamoxifen to induce caspase-mediated apoptosis in breast cancer cells. Mol. Cancer Ther. 2008, 7, 3056-3063.
46. Yin, S.; Dong, Y.; Li, J.; Fan, L.; Wang, L.; Lu, J.; Vang, O.; Hu, H. Methylseleninic acid potentiates multiple types of cancer cells to ABT-737-induced apoptosis by targeting Mcl-1 and Bad. Apoptosis 2012, 17, 388-399.
47. Qi, Y.; Fu, X.; Xiong, Z.; Zhang, H.; Hill, S.M.; Rowan, B.G.; Dong, Y. Methylseleninic acid enhances paclitaxel efficacy for the treatment of triple-negative breast cancer. PLoS One 2012, 7, e31539.
48. Rudolf, E.; Rudolf, K.; Cervinka, M. Selenium activates p53 and p38 pathways and induces caspase-independent cell death in cervical cancer cells. Cell Biol. Toxicol. 2008, 24, 123-141.
49. Freitas, M.; Alves, V.; Sarmento-Ribeiro, A.B.; Mota-Pinto, A. Combined effect of sodium selenite and docetaxel on Pc3 metastatic prostate cancer cell line. Biochem. Biophys. Res. Commun. 2011, 408, 713-719.
50. Kim, B.; Rode, A.; Han, E.; Hong, I.; Hong, S. 5-phenylselenyl- and 5-methylselenyl-methyl-2'- deoxyuridine induce oxidative stress, DNA damage, and caspase-2-dependent apoptosis in cancer cells. Apoptosis 2012, 17, 200-216.
51. Kim, B.M.; Lee, K.H.; Hong, I.S.; Hong, S.H. P38 mitogen-activated protein kinase is a key regulator of 5-phenylselenyl- and 5-methylselenyl-methyl-2'-deoxyuridine-induced apoptosis in human HL-60 cells. Biochem. Biophys. Res. Commun. 2012, 417, 237-244.
52. Thant, A.A.; Wu, Y.; Lee, J.; Mishra, D.K.; Garcia, H.; Koeffler, H.P.; Vadgama, J.V. Role of caspases in 5-FU and selenium-induced growth inhibition of colorectal cancer cells. Anticancer Res. 2008, 28, 3579-3592.
53. Montero, A.J.; Jassem, J. Cellular redox pathways as a therapeutic target in the treatment of cancer. Drugs 2011, 71, 1385-1396.
54. Ray, P.D.; Huang, B.W.; Tsuji, Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 2012, 24, 981-990.
55. Takahashi, M.; Sato, T.; Shinohara, F.; Echigo, S.; Rikiishi, H. Possible role of glutathione in mitochondrial apoptosis of human oral squamous cell carcinoma caused by inorganic selenium compounds. Int. J. Oncol. 2005, 27, 489-495.
56. Misra, S.; Niyogi, S. Selenite causes cytotoxicity in rainbow trout (Oncorhynchus mykiss) hepatocytes by inducing oxidative stress. Toxicol. Vitr. 2009, 23, 1249-1258.
57. Misra, S.; Hamilton, C.; Niyogi, S. Induction of oxidative stress by selenomethionine in isolated hepatocytes of rainbow trout (Oncorhynchus mykiss). Toxicol. Vitr. 2012, 26, 621-629.
58. Chen, J.J.; Boylan, L.M.; Wu, C.K.; Spallholz, J.E. Oxidation of glutathione and superoxide generation by inorganic and organic selenium compounds. Biofactors 2007, 31, 55-66.
59. Plano, D.; Baquedano, Y.; Ibáñez, E.; Jiménez, I.; Palop, J.A.; Spallholz, J.E.; Sanmartín, C. Antioxidant-prooxidant properties of a new organoselenium compound library. Molecules 2010, 15, 7292-7312.
60. Kunwar, A.; Bansal, P.; Kumar, S.J.; Bag, P.P.; Paul, P.; Reddy, N.D.; Kumbhare, L.B.; Jain, V.K.; Chaubey, R.C.; Unnikrishnan, M.K.; et al. In vivo radioprotection studies of 3,3′-diselenodipropionic acid, a selenocystine derivative. Free Radic. Biol. Med. 2010, 48, 399-410.
61. Liu, C.; Chen, J.; Wu, Z.; Li, Y.; Zhu, Y.; Ren, Y.; Zhou, Q. Selenium compounds induce ROS in human high-metastatic large cell lung cancer cell line L9981. Zhongguo Fei Ai Za Zhi 2008, 11, 354-358.
62. Liu, C.; Liu, H.; Li, Y.; Wu, Z.; Zhu, Y.; Wang, T.; Gao, A.C.; Chen, J.; Zhou, Q. Intracellular glutathione content influences the sensitivity of lung cancer cell lines to methylseleninic acid. Mol. Carcinog. 2011, 22, doi:10.1002/mc.20781.
63. Papp, L.V.; Lu, J.; Bolderson, E.; Boucher, D.; Singh, R.; Holmgren, A.; Khanna, K.K. SECIS-binding protein 2 promotes cell survival by protecting against oxidative stress. Antioxid. Redox Signal. 2010, 12, 797-808.
64. Poerschke, R.L.; Moos, P.J. Thioredoxin reductase 1 knockdown enhances selenazolidine cytotoxicity in human lung cancer cells via mitochondrial dysfunction. Biochem. Pharmacol. 2011, 81, 211-221.
65. Honeggar, M.; Beck, R.; Moos, P.J. Thioredoxin reductase 1 ablation sensitizes colon cancer cells to methylseleninate-mediated cytotoxicity. Toxicol. Appl. Pharmacol. 2009, 241, 348-355.
66. Wang, L.; Yang, Z.; Fu, J.; Yin, H.; Xiong, K.; Tan, Q.; Jin, H.; Li, J.; Wang, T.; Tang, W.; et al. Ethaselen: A potent mammalian thioredoxin reductase 1 inhibitor and novel organoselenium anticancer agent. Free Radic. Biol. Med. 2012, 52, 898-908.
67. Liu, X.; Pietsch, K.E.; Sturla, S.J. Susceptibility of the antioxidant selenoenyzmes thioredoxin reductase and glutathione peroxidase to alkylation-mediated inhibition by anticancer acylfulvenes. Chem. Res. Toxicol. 2011, 24, 726-736.
68. De Souza Prestes, A.; Stefanello, S.T.; Salman, S.M.; Pazini, A.M.; Schwab, R.S.; Braga, A.L.; de Vargas Barbosa, N.B.; Rocha, J.B. Antioxidant activity of beta-selenoamines and their capacity to mimic different enzymes. Mol. Cell Biochem. 2012, 365, 85-92.
69. Gundimeda, U.; Schiffman, J.E.; Chhabra, D.; Wong, J.; Wu, A.; Gopalakrishna, R. Locally generated methylseleninic acid induces specific inactivation of protein kinase C isoenzymes: Relevance to selenium-induced apoptosis in prostate cancer cells. J. Biol. Chem. 2008, 283, 34519-34531.
70. Selenius, M.; Rundlof, A.K.; Olm, E.; Fernandes, A.P.; Bjornstedt, M. Selenium and the selenoprotein thioredoxin reductase in the prevention, treatment and diagnostics of cancer. Antioxid. Redox Signal. 2010, 12, 867-880.
71. Krehl, S.; Loewinger, M.; Florian, S.; Kipp, A.; Banning, A.; Wessjohann, L.; Brauer, M.; Iori, R.; Esworthy, R.S.; Chu, F.-F.; et al. Glutathione peroxidase-2 and selenium decreased inflammation and tumors in a mouse model of inflammation-associated carcinogenesis whereas sulforaphane effects differed with selenium supply. Carcinogenesis 2012, 33, 620-628.
72. Hawkes, W.C.; Alkan, Z. Delayed cell cycle progression from SEPW1 depletion is p53- and p21-dependent in MCF-7 breast cancer cells. Biochem. Biophys. Res. Commun. 2011, 413, 36-40.
73. Bjelogrlic, S.; Todorovic, T.; Bacchi, A.; Zec, M.; Sladic, D.; Srdic-Rajic, T.; Radanovic, D.; Radulovic, S.; Pelizzi, G.; Andelkovic, K. Synthesis, structure and characterization of novel Cd(II) and Zn(II) complexes with the condensation product of 2-formylpyridine and selenosemicarbazide antiproliferative activity of the synthesized complexes and related selenosemicarbazone complexes. J. Inorg. Biochem. 2010, 104, 673-682.
74. Srdić-Rajić, T.; Zec, M.; Todorović, T.; Andelković, K.; Radulović, S. Non-substituted n-heteroaromatic selenosemicarbazone metal complexes induce apoptosis in cancer cells via activation of mitochondrial pathway. Eur. J. Med. Chem. 2011, 46, 3734-3747.
75. Das, A.; Bortner, J.; Desai, D.; Amin, S.; El-Bayoumy, K. The selenium analog of the chemopreventive compound S,S'-(1,4-phenylenebis[1,2-ethanediyl])bisisothiourea is a remarkable inducer of apoptosis and inhibitor of cell growth in human non-small cell lung cancer. Chem. Biol. Interact. 2009, 180, 158-164.
76. Chen, T.; Wong, Y.S. Selenocystine induces caspase-independent apoptosis in MCF-7 human breast carcinoma cells with involvement of p53 phosphorylation and reactive oxygen species generation. Int. J. Biochem. Cell Biol. 2009, 41, 666-676.
77. Guan, L.; Huang, F.; Li, Z.; Han, B.; Jiang, Q.; Ren, Y.; Yang, Y.; Xu, C. P53 transcription-independent activity mediates selenite-induced acute promyelocytic leukemia NB4 cell apoptosis. BMB Rep. 2008, 41, 745-750.
78. Sarveswaran, S.; Liroff, J.; Zhou, Z.; Nikitin, A.Y.; Ghosh, J. Selenite triggers rapid transcriptional activation of p53, and p53-mediated apoptosis in prostate cancer cells: Implication for the treatment of early-stage prostate cancer. Int. J. Oncol. 2010, 36, 1419-1428.
79. Abdulah, R.; Kobayashi, K.; Yamazaki, C.; Koyama, H. Molecular targets of selenium in prostate cancer prevention (review). Int. J. Oncol. 2011, 39, 301-309.
80. Suzuki, M.; Endo, M.; Shinohara, F.; Echigo, S.; Rikiishi, H. Differential apoptotic response of human cancer cells to organoselenium compounds. Cancer Chemother. Pharmacol. 2010, 66, 475-484.
81. Jun-Ying, Y.; Cun-Shuan, X. Antitumor effects of a selenium heteropoly complex in K562 cells. Pharmacol. Rep. 2009, 61, 288-295.
82. Yang, J.; Yang, X.; Fan, J.; Zhao, Q.; Xu, C. The novel selenium heteropoly compound (NH4)4H4[Se2Mo2V4O24].7H2O induces apoptosis of K562 cells. Mol. Med. Rep. 2011, 4, 1327-1332.
83. Lee, J.T.; Lee, T.J.; Park, J.W.; Kwon, T.K. Se-methylselenocysteine sensitized TRAIL-mediated apoptosis via down-regulation of bcl-2 expression. Int. J. Oncol. 2009, 34, 1455-1460.
84. Lin, T.; Ding, Z.; Li, N.; Xu, J.; Luo, G.; Liu, J.; Shen, J. Seleno-cyclodextrin sensitises human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-kappaB suppression. Eur. J. Cancer 2011, 47, 1890-1907.
85. Shang, D.; Zhang, J.; Wen, L.; Li, Y.; Cui, Q. Preparation, characterization, and antiproliferative activities of the se-containing polysaccharide SeGLP-2B-1 from Se-enriched Ganoderma lucidum. J. Agric. Food Chem. 2009, 57, 7737-7742.
86. Shang, D.; Li, Y.; Wang, C.; Wang, X.; Yu, Z.; Fu, X. A novel polysaccharide from Se-enriched Ganoderma lucidum induces apoptosis of human breast cancer cells. Oncol. Rep. 2011, 25, 267-272.
87. Abdulah, R.; Faried, A.; Kobayashi, K.; Yamazaki, C.; Suradji, E.; Ito, K.; Suzuki, K.; Murakami, M.; Kuwano, H.; Koyama, H. Selenium enrichment of broccoli sprout extract increases chemosensitivity and apoptosis of LNCaP prostate cancer cells. BMC Cancer 2009, 9, doi:10.1186/1471-2407-9-414.
88. Tsubura, A.; Lai, Y.C.; Kuwata, M.; Uehara, N.; Yoshizawa, K. Anticancer effects of garlic and garlic-derived compounds for breast cancer control. Anticancer Agents Med. Chem. 2011, 11, 249-253.
89. Kumi-Diaka, J.; Merchant, K.; Haces, A.; Hormann, V.; Johnson, M. Genistein-selenium combination induces growth arrest in prostate cancer cells. J. Med. Food 2010, 13, 842-850.
90. Azrak, R.G.; Cao, S.; Durrani, F.A.; Toth, K.; Bhattacharya, A.; Rustum, Y.M. Augmented therapeutic efficacy of irinotecan is associated with enhanced drug accumulation. Cancer Lett. 2011, 311, 219-229.
91. Chakraborty, P.; Sk, U.H.; Bhattacharya, S. Chemoprotection and enhancement of cancer chemotherapeutic efficacy of cyclophosphamide in mice bearing ehrlich ascites carcinoma by diphenylmethyl selenocyanate. Cancer Chemother. Pharmacol. 2009, 64, 971-980.
92. Cheng, Y.; Sk, U.H.; Zhang, Y.; Ren, X.; Zhang, L.; Huber-Keener, K.J.; Sun, Y.-W.; Liao, J.; Amin, S.; Sharma, A.K.; et al. Rational incorporation of selenium into temozolomide elicits superior antitumor activity associated with both apoptotic and autophagic cell death. PLoS One 2012, 7, e35104.
93. Kim, J.H.; Hue, J.J.; Kang, B.S.; Park, H.; Nam, S.Y.; Yun, Y.W.; Kim, J.S.; Lee, B.J. Effects of selenium on colon carcinogenesis induced by azoxymethane and dextran sodium sulfate in mouse model with high-iron diet. Lab. Anim. Res. 2011, 27, 9-18.
94. Rikiishi, H. Autophagic and apoptotic effects of HDAC inhibitors on cancer cells. J. Biomed. Biotechnol. 2011, 2011, doi:10.1155/2011/830260.
95. Rikiishi, H. Novel insights into the interplay between apoptosis and autophagy. Int. J. Cell Biol. 2012, 2012, doi:10.1155/2012/317645.
96. Long, J.; Zhao, J.; Yan, Z.; Liu, Z.; Wang, N. Antitumor effects of a novel sulfur-containing hydroxamate histone deacetylase inhibitor H40. Int. J. Cancer 2009, 124, 1235-1244.
97. Gammoh, N.; Lam, D.; Puente, C.; Ganley, I.; Marks, P.A.; Jiang, X. Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell death. Proc. Natl. Acad. Sci. USA 2012, doi:10.1073/pnas.1204429109.
98. Desai, D.; Salli, U.; Vrana, K.E.; Amin, S. SelSA, selenium analogs of SAHA as potent histone deacetylase inhibitors. Bioorg. Med. Chem. Lett. 2010, 20, 2044-2047.
99. Karelia, N.; Desai, D.; Hengst, J.A.; Amin, S.; Rudrabhatla, S.V.; Yun, J. Selenium-containing analogs of SAHA induce cytotoxicity in lung cancer cells. Bioorg. Med. Chem. Lett. 2010, 20, 6816-6819.
100. Sanmartin, C.; Plano, D.; Palop, J.A. Selenium compounds and apoptotic modulation: A new perspective in cancer therapy. Mini-Rev. Med. Chem. 2008, 8, 1020-1031.
101. Kim, Y.W.; Bae, S.M.; Liu, H.B.; Kim, I.W.; Chun, H.J.; Ahn, W.S. Selenium enhances the efficacy of radachlorin mediated-photodynamic therapy in TC-1 tumor development. Oncol. Rep. 2012, 28, 576-584.
102. Filomeni, G.; Piccirillo, S.; Rotilio, G.; Ciriolo, M.R. P38MAPK and ERK1/2 dictate cell death/survival response to different pro-oxidant stimuli via p53 and Nrf2 in neuroblastoma cells SH-SY5Y. Biochem. Pharmacol. 2012, 83, 1349-1357.
103. Huang, C.; Ding, G.; Gu, C.; Zhou, J.; Kuang, M.; Ji, Y.; He, Y.; Kondo, T.; Fan, J. Decreased selenium-binding protein 1 enhances glutathione peroxidase 1 activity and downregulates HIF-1alpha to promote hepatocellular carcinoma invasiveness. Clin. Cancer Res. 2012, 18, 3042-3053.
104. Wang, D.; Taylor, E.; Wang, Y.; Wan, X.; Zhang, J. Encapsulated nanoepigallocatechin-3-gallate and elemental selenium nanoparticles as paradigms for nanochemoprevention. Int. J. Nanomed. 2012, 7, 1711-1721.
105. Suradji, E.W.; Hatabu, T.; Kobayashi, K.; Yamazaki, C.; Abdulah, R.; Nakazawa, M.; Nakajima-Shimada, J.; Koyama, H. Selenium-induced apoptosis-like cell death in Plasmodium falciparum. Parasitology 2011, 19, 1-11.
106. Afoulous, S.; Ferhout, H.; Raoelison, E.G.; Valentin, A.; Moukarzel, B.; Couderc, F.; Bouajila, J. Helichrysum gymnocephalum essential oil: Chemical composition and cytotoxic, antimalarial and antioxidant activities, attribution of the activity origin by correlations. Molecules 2011, 16, 8273-8291.
107. Moreno, D.; Plano, D.; Baquedano, Y.; Jimenez-Ruiz, A.; Palop, J.A.; Sanmartin, C. Antileishmanial activity of imidothiocarbamates and imidoselenocarbamates. Parasitol. Res. 2011, 108, 233-239.
108. Singh, K.; Kaur, H.; Chibale, K.; Balzarini, J.; Little, S.; Bharatam, P.V. 2-aminopyrimidine based 4-aminoquinoline anti-plasmodial agents. Synthesis, biological activity, structure-activity relationship and mode of action studies. Eur. J. Med. Chem. 2012, 52, 82-97.
109. Jamier, V.; Ba, L.A.; Jacob, C. Selenium- and tellurium-containing multifunctional redox agents as biochemical redox modulators with selective cytotoxicity. Chemistry 2010, 16, 10920-10928.
110. Ramoutar, R.R.; Brumaghim, J.L. Antioxidant and anticancer properties and mechanisms of inorganic selenium, oxo-sulfur, and oxo-selenium compounds. Cell Biochem. Biophys. 2010, 58, 1-23.
111. Lee, K.H.; Jeong, D. Bimodal actions of selenium essential for antioxidant and toxic pro-oxidant activities: The selenium paradox (review). Mol. Med. Rep. 2012, 5, 299-304.